US chemical group DuPont has successfully completed its tender offer for Danisco, as 92.2 percent of outstanding shares in the Danish food ingredients firm were tendered by Friday’s deadline, DuPont said on Monday.
The European Commission today approved DuPont’s €4.5bn offer for Danish probiotics, enzymes and ingredients giant Danisco but the deal remains in doubt as to date only 6% of Danisco shareholders have accepted the offer.
DuPont would look to move its food ingredients R&D to Denmark following its acquisition of Danisco, and adopt the latter’s Sales and Application development organisation to get ingredients to market, offer documents reveal.
Danisco is to be snapped up by DuPont for $6.3bn, in a deal Dupont says could create a global leader in industrial biotech – and help drive science-based solutions to the world’s food and fuel challenges.
Danisco has completed the next phase of its cultures capacity expansion with the opening of modernised and enlarged facilities in Epernon, France, allowing it to reduce response times for DVI cultures.
Danisco said that the development of Grindsted Fibreline 103, an addition to its Fibreline 101 product for rye bread applications, enables bakers to meet consumer demand for healthier bread without compromising on taste or texture.
The food and beverage enzyme market looks set to continue growing, says Danisco chief, as food firms turn to processing aid to solve issues of cost, safety and quality, and new health and nutrition benefits are uncovered.
Danish supplier Danisco BioActives and Norwegian vitamin K specialist, NattoPharma, have inked a deal that will see Danisco become the marketer and distributor of Natto’s vitamin K2 ingredient to the food industry.
Rumour, according to the Romans, is a feathered beast with a myriad eyes and tongues. Last week she went bristling through the Danish business pages, spreading the news that Danisco could be bought by a private equity firm.
The strength of Danisco Cultures is reflected in the company's
financial report for the first nine months of 2006/7, in which the
division helped drive organic growth for both Bioingredients and
its overarching Ingredients sector.
Danisco has developed a new formulation of probiotics called Howaru
Protect, specifically targeted to reducing cold and 'flu symptoms,
and is exploring its use by the food, supplements and
Oral administration of Lactobacillous acidophilus NCFM has been
seen to have an analgesic effect in the gut similar to that of
morphine - a finding that opens up a new realm of applications for
Danisco's probiotic strain.
Danisco is introducing a new addition to its Howru probiotics line,
which it says was seen in the first of a series of
condition-specific studies to help restore the beneficial bacteria
in the human gut after taking antibiotics.
Danisco is setting out to encourage new ideas for appealing and
science-based functional foods; at the start of this month it held
a symposium to present an insight into opportunities for improving
consumer health through diet.
Danisco has taken up the low-carb, low-sugar baton and run with it,
developing a line of flavours aimed at food manufacturers
developing artificially sweetened and reduced sugar beverages and